Ziteng Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Venous Thromboembolism

Oral Anticoagulants

Top Venues

British journal of clinical pharmacology

Clinical pharmacology and therapeutics

CPT: pharmacometrics & systems pharmacology

Drug metabolism and disposition: the biological fate of chemicals

This page only lists publications with an associated author ORCID identifier.

Publications

Lixuan Qian, Ziteng Wang, Mary F Paine, Eric Chun Yong Chan, Zhu Zhou
Application of physiologically-based pharmacokinetic modeling to inform dosing decisions for geriatric patients. CPT: pharmacometrics & systems pharmacology (2024)
Tat Ming Ng, Ziteng Wang, Eric Chun Yong Chan
Physiologically-based pharmacokinetic modelling guided dose evaluations of nirmatrelvir/ritonavir in renal impairment for the management of COVID-19. British journal of clinical pharmacology (2024)
Ziteng Wang, Kylie Hoi Yan Luk, Eleanor Jing Yi Cheong, Sin Mun Tham, Revathi Periaswami, Poh Choo Toh, Ziting Wang, Qing Hui Wu, Woon Chau Tsang, Arshvin Kesavan, Alvin Seng Cheong Wong, Patrick Thomas Wong, Felicia Lim, Edmund Chiong, Eric Chun Yong Chan
Characterization and prediction of OATP1B activity in prostate cancer patients on abiraterone acetate using endogenous biomarker coproporphyrin I. Drug metabolism and disposition: the biological fate of chemicals (2024)
Eleanor Jing Yi Cheong, Sheng Yuan Chin, Zheng Wei Ng, Ting Jian Yap, Ervin Zhi Bin Cheong, Ziteng Wang, Eric Chun Yong Chan
Unraveling Complexities in the Absorption and Disposition Kinetics of Abiraterone via Iterative PBPK Model Development and Refinement. Clinical pharmacokinetics (2023)
Ziteng Wang, Eric Chun Yong Chan
Role of Cytochrome P450 2C8 in Drug-Drug Interaction between Amiodarone and Nirmatrelvir/Ritonavir Via Physiologically-Based Pharmacokinetic Modeling. Clinical pharmacology and therapeutics (2023)
Keane Zhi Hao Lee, Ziteng Wang, Ching Yee Fong, Evelyn Mei Ling Goh, Hooi Moy Yan, Eric Chun Yong Chan
Identification of Optimal Urinary Biomarkers of Synthetic Cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID, and BZO-CHMOXIZID for Illicit Abuse Monitoring. Clinical chemistry 68 (11) (2022)
Ziteng Wang, Eric Chun Yong Chan
Physiologically-Based Pharmacokinetic Modeling-Guided Dose Management of Oral Anticoagulants when Initiating Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 Treatment. Clinical pharmacology and therapeutics 112 (4) (2022)
Eleanor Jing Yi Cheong, Daniel Zhi Wei Ng, Sheng Yuan Chin, Ziteng Wang, Eric Chun Yong Chan
Application of a PBPK Model of Rivaroxaban to Prospective Simulations of Drug-Drug-Disease Interactions with Protein Kinase Inhibitors in CA-VTE. British journal of clinical pharmacology (2021)
Ziteng Wang, Ching Yee Fong, Evelyn Mei Ling Goh, Hooi Moy Yan, Eric Chun Yong Chan
Transesterification of Indazole-3-Carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarker for Diagnosing Co-Abuse of 5F-MDMB-PINACA and Alcohol. Journal of analytical toxicology (2021)